HGS gets contract for anthrax drug
3rd Oct 2005, 16:12 GMT
With numerous biotechnology companies racing to bring a drug for treating anthrax to market, Human Genome Sciences has received a vote of confidence from the federal government, winning a $1.8 million contract worth potentially much more from the U.S. Department of Health and Human Services.
HGS gets contract for anthrax drug related news:
- HGS gets contract for anthrax drug — Financial News News from StratCenter.com
- Human Genome Sciences gets anthrax drug contract — Latest news from Baltimore Business Journal
- Federal Pact Lifts Drug Firm — Financial News News from StratCenter.com
- Biotech Firm Gets Anthrax Drug Deal. — Environmental Health News
- Government Signs Anthrax Drug Deal (Associated Press) —
- Human Genome to get U.S. govt anthrax drug deal — KeralaNext: Health
- Human Genome to get U.S. govt anthrax drug deal (Reuters) — Yahoo! News: Health News
- Biotech Firm Gets Anthrax Drug Deal — washingtonpost.com - Technology - Industry News, Policy, and Reviews
- Government Signs Anthrax Drug Deal — AP Top Health News At 3:12 p.m. EDT
- Human Genome Sciences Lands $1.8B Anthrax Contract — Rednova News - Health
Latest news from bizjournals.com Health Care:Biotechnology headlines:
- Baylor researchers make heart disease finding
- ZymoGenetics encouraged by early results on lupus treatment
- ActivBiotics shelves IPO plans
- Delta Search Labs spinoff wins Air Force deal for toxin detector
- UTSA joins regional research university alliance on border security
- Intact Medical launches breast cancer detection device